177 related articles for article (PubMed ID: 25247884)
1. Characterization of commercially available vaginal lubricants: a safety perspective.
Cunha AR; Machado RM; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; das Neves J; Palmeira-de-Oliveira R
Pharmaceutics; 2014 Sep; 6(3):530-42. PubMed ID: 25247884
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial on the effectiveness and safety of 5 water-based personal lubricants.
Palacios S; Hood S; Abakah-Phillips T; Savania N; Krychman M
J Sex Med; 2023 Mar; 20(4):498-506. PubMed ID: 36781402
[TBL] [Abstract][Full Text] [Related]
3. Effects of Vaginal Lubricants on In-Vitro Progressive Spermatozoa Motility.
Wilson SL; Adam JK; Krishna SBN
Afr J Reprod Health; 2017 Sep; 21(3):96-101. PubMed ID: 29624933
[TBL] [Abstract][Full Text] [Related]
4. Qualification of a non-animal vaginal irritation method admitted as nonclinical assessment model (NAM) in the Incubator Phase of the United States Food and Drug Administration (US FDA) Medical Devices Development Tool (MDDT).
Costin GE; Hill E; Brown J; Clippinger AJ
Toxicol In Vitro; 2020 Feb; 62():104680. PubMed ID: 31626901
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Hyperosmolal vaginal lubricants markedly reduce epithelial barrier properties in a three-dimensional vaginal epithelium model.
Ayehunie S; Wang YY; Landry T; Bogojevic S; Cone RA
Toxicol Rep; 2018; 5():134-140. PubMed ID: 29854584
[TBL] [Abstract][Full Text] [Related]
7. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
Edwards D; Panay N
Climacteric; 2016 Apr; 19(2):151-61. PubMed ID: 26707589
[TBL] [Abstract][Full Text] [Related]
8. Mucosal irritation potential of personal lubricants relates to product osmolality as detected by the slug mucosal irritation assay.
Adriaens E; Remon JP
Sex Transm Dis; 2008 May; 35(5):512-6. PubMed ID: 18356773
[TBL] [Abstract][Full Text] [Related]
9. Personal and Clinical Vaginal Lubricants: Impact on Local Vaginal Microenvironment and Implications for Epithelial Cell Host Response and Barrier Function.
Wilkinson EM; Łaniewski P; Herbst-Kralovetz MM; Brotman RM
J Infect Dis; 2019 Nov; 220(12):2009-2018. PubMed ID: 31539059
[TBL] [Abstract][Full Text] [Related]
10. Consumer protection provided by the European medical device and cosmetic legislation for condoms and lubricants.
Desmedt B; Vanhamme M; Vanhee C; Rogiers V; Deconinck E
Regul Toxicol Pharmacol; 2019 Apr; 103():106-112. PubMed ID: 30659873
[TBL] [Abstract][Full Text] [Related]
11. Vaginal lubricants and moisturizers: a review into use, efficacy, and safety.
Potter N; Panay N
Climacteric; 2021 Feb; 24(1):19-24. PubMed ID: 32990054
[TBL] [Abstract][Full Text] [Related]
12. Sexual lubricants in South Africa may potentially disrupt mucosal surfaces and increase HIV transmission risk among men who have sex with men.
Rebe KB; De Swardt G; Berman PA; Struthers H; McIntyre JA
S Afr Med J; 2013 Oct; 104(1):49-51. PubMed ID: 24388089
[TBL] [Abstract][Full Text] [Related]
13. Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro.
Begay O; Jean-Pierre N; Abraham CJ; Chudolij A; Seidor S; Rodriguez A; Ford BE; Henderson M; Katz D; Zydowsky T; Robbiani M; Fernández-Romero JA
AIDS Res Hum Retroviruses; 2011 Sep; 27(9):1019-24. PubMed ID: 21309617
[TBL] [Abstract][Full Text] [Related]
14. Condoms and condiments: compatibility and safety of personal lubricants and their use in Africa.
Geibel S
J Int AIDS Soc; 2013 Jul; 16(1):18531. PubMed ID: 23841994
[TBL] [Abstract][Full Text] [Related]
15. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
16. Vaginal semisolid products: Technological performance considering physiologic parameters.
Machado RM; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Palmeira-de-Oliveira R
Eur J Pharm Sci; 2017 Nov; 109():556-568. PubMed ID: 28887234
[TBL] [Abstract][Full Text] [Related]
17. Lubricants for the promotion of sexual health and well-being: a systematic review.
Kennedy CE; Yeh PT; Li J; Gonsalves L; Narasimhan M
Sex Reprod Health Matters; 2021; 29(3):2044198. PubMed ID: 35315312
[TBL] [Abstract][Full Text] [Related]
18. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
[No Abstract] [Full Text] [Related]
19. Effect of topical vaginal products on the detection of prostate-specific antigen, a biomarker of semen exposure, using ABAcards.
Snead MC; Kourtis AP; Black CM; Mauck CK; Brown TM; Penman-Aguilar A; Melendez JH; Gallo MF; Jamieson DJ; Macaluso M
Contraception; 2013 Sep; 88(3):382-6. PubMed ID: 23218862
[TBL] [Abstract][Full Text] [Related]
20. Characterization and classification of water-based compounds in condoms and personal hygiene products using GC-MS.
Burnier C; Massonnet G; Coulson S; DeTata D; Pitts K
Forensic Sci Int; 2020 Dec; 317():110513. PubMed ID: 32987281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
